- Country: USA
- Summary: Microbiome-Targeted and Global Assay Testing for Laboratory Medicine
- UST Ref No: 89168396
- Deadline: 22 Sep 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 23-010271
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The National Institutes of Health (NIH) intends to award a fixed priced purchase order for a one year base period and one (1) twelve month option period on a sole source basis to Metabolon, Inc., Morrisville, North Carolina, 27560, UEI: SBY5A7EK9PU3 for testing services needed to support a clinical research study. Metabolon offers microbiome-targeted and global assay testing not performed in the Clinical Center Department of Laboratory Medicine (DLM) laboratory.
The primary objective of the study is to examine associations between diet and the gut microbiome. A secondary objective is examining the associations between the gut microbiome and changes in metabolites.
The proposed vendor, Metabolon, Inc., specializes in the bioanalysis and data interpretation of metabolomics for the mechanistic understanding of biomarkers at a cellular level. Metabolon sets itself apart with superior analytical and bioinformatics technologies, which together produce high-quality data via a high-throughput workflow. Metabolon proprietary bioinformatics technology rapidly sorts through massive amounts of biochemical data, extracting only the significant information. These technologies, combined with rigorous QC processes, allow for the most comprehensive, high quality, and accurate metabolomics data to be rapidly transformed into knowledge that scientists can immediately put into action; a technology Metabolon calls, Precision Metabolomics™. It is critical to put DLM study results into context, to compare the new testing data to the existing results from similar clinical trials that performed testing at Metabolon.
Metabolon Inc. has unique qualifications in that it is the only company that offers Bile acids, and Short Chain Fatty Acids, and untargeted metabolomics on the combination of specimens for the study including stool and urine and plasma. Metabolon has also been cited in numerous publications within the research field that will allow DLM ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINMicrobiome-Targeted and Global Assay Testing for Laboratory Medicine - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Microbiome-Targeted and Global Assay Testing for Laboratory Medicine. This tender is published on USARFP under UST Ref No: 89168396 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-09-22.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
